Table 2.
PT | DTT-NFGN/Organism | MIC90 for CZA (mg/L) | Other Organism | Previous/Empirical Treatment Regimen | CZA Regimen | Days of Therapy |
---|---|---|---|---|---|---|
PT1 | S. maltophila | 2 | K. pneumoniae ESBL | FDC then MEM | CZA EI 5 g every 12 h + MEM EI1 g every 8 h | 27 |
PT2 | B. cepacia | 4 | CZA EI 5 g every 12 h + FOF 24 g CI | 12 | ||
PT3 | P. aeruginosa | 2 | MEM | CZA EI 1.25 g every 8 h + AMK inhaled | 9 | |
PT4 | P. aeruginosa | 2 | S. marcescens | FEP | CZA EI 5 g every 12 h + FOF 24 g CI | 6 |
PT5 | P. aeruginosa | 8 | K. pneumoniae | CAZ then TZP then MEM | CZA II over 2 h of 2.5 g + AMK inhaled | 18 |
PT6 | P. aeruginosa | 4 | S. marcescens Colistin-R | MEM | CZA EI 1.25 g every 8 h + FOF 2 g every 48 h, after a dialytic session | 18 |
PT7 | P. aeruginosa | 16 | COL + AMK inhaled | CZA EI 5 g every 12 h + FOF 24 g CI + MEM EI 1 g every 8 h | 8 | |
PT8 | P. aeruginosa | 16 | K. pneumoniae KPC | CZA EI 5 g every 12 h + FOF 24 g CI then FOF was stopped and FDC 2 g EI every 8 h was started | 21 | |
PT9 | P. aeruginosa | 16 | K. pneumoniae | CZA EI 1.25 g every 8 h | 3 | |
PT10 | P. fluorescens | 2 | MEM | CZA EI 1.25 g every 8 h + MER 1 g EI every 12 h | 9 | |
PT11 | P. aeruginosa | 16 | K. pneumoniae ESBL | MEM + AMK inhaled | CZA EI 5 g every 12 h + FOF 24 g CI, then FOF was stopped and FDC 2 g EI every 8 h was started | 5 |
PT12 | S. maltophila | 16 | SXT + AMP | CZA EI 5 g every 12 h + SXT 15 mg/kg/day | 11 | |
PT13 | P. aeruginosa | 8 | MEM | CZA II over 2 h of 2.5 g + FOF 24 g CI, then FOF was stopped, and FDC 2 g EI every 8 h was started | 9 | |
PT14 | P. putida | 8 | S. maltophila | FEP | CZA EI 5 g every 12 h + FOF 24 g CI | 10 |
PT15 | P. aeruginosa | 4 | S. marcescens ESBL | MEM | CZA EI 5 g every 12 h + FOF 24 g cCI | 9 |
PT16 | P. aeruginosa | 8 | S. maltophila | MEM | CZA EI 5 g every 12 h + FOF 24 g CI | 25 |
PT17 | B. cepacia | 16 | E. cloacae ESBL | MEM | CZA EI 5 g every 12 h + SXT 15 mg/kg/day | 9 |
PT18 | P. aeruginosa | 2 | S. maltophila | MEM | CZA EI 5 g every 12 h | 10 |
PT19 | P. aeruginosa | 2 | TZP | CZA EI 5 g every 12 h + MER EI every 8 h | 5 | |
PT20 | S. maltophila | 16 | CZA EI 5 g every 12 h + AZT 2 g every 8 h | 7 | ||
PT21 | P. aeruginosa | 2 | MEM | CZA EI 1.25 g every 8 h + AMK inhaled | 12 | |
PT22 | P. aeruginosa | 2 | P. aeruginosa | CAZ then MEM | CZA EI 1.25 g every 8 h + MEM 1 g EI every 8 h | 5 |
PT23 | P. aeruginosa | 2 | CAZ then C/T | CZA EI 1.25 g every 8 h + MEM 1 g EI every 8 h | 4 |
EI = extended infusion, II = intermittent infusion, CI = continuous infusion, FDC = cefiderocol, MEM = meropenem, FEP = cefepime, TZP = piperacillin/tazobactam, CAZ = ceftazidime, COL = colistin, AMP = ampicillin, STX = trimethoprim-sulfamethoxazole, CZA = ceftazidime/avibactam, FOF = fosfomycin, and AMK = amikacin.